A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/1992
11/10/1992	CA1309950C Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
11/10/1992	CA1309949C Contraceptive implant
11/10/1992	CA1309948C Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
11/09/1992	WO1992019267A1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
11/08/1992	WO1992019241A1 A controlled, sustained release delivery system for smoking cessation
11/08/1992	CA2102507A1 A controlled, sustained release delivery system for smoking cessation
11/07/1992	CA2067989A1 Composition for disclosing dental plaque
11/04/1992	WO1992019752A1 Rna delivery vector
11/04/1992	WO1992019232A1 Partial liquid breathing of fluorocarbons
11/04/1992	EP0511800A1 Pharmaceutical formulation containing dirithromycin
11/04/1992	EP0511799A1 Pharmaceutical compounds
11/04/1992	EP0511782A1 Polymer composition for tooth bleaching and other dental uses thereof
11/04/1992	EP0511767A1 Tablets containing compound DUP753
11/04/1992	EP0511292A1 Polyanhydrides of the oligomerized unsaturated aliphatic acids
11/04/1992	EP0511273A1 Liposomes as contrast agents for ultrasonic imaging
11/04/1992	EP0511234A1 Stable injectible solutions for factor viii.
11/04/1992	EP0511224A1 Cloth impregnated with an active substance
11/04/1992	EP0491853A4 Transdermal delivery device having delayed onset
11/04/1992	CN1065797A Process for producing infantile stomach medicine pill "weibaowan"
11/04/1992	CA2086510A1 Rna delivry vector
11/03/1992	WO1992019229A1 Modified pollen grains for delivering biologically active substances to plants and animals
11/03/1992	US5160745 Biodegradable microspheres as a carrier for macromolecules
11/03/1992	US5160744 Verapmil therapy
11/03/1992	US5160743 Mixture of cellulose derivatives, plasticizer, and emulsifier; drug delivery; solvent-free
11/03/1992	US5160742 System for delivering an active substance for sustained release
11/03/1992	US5160740 Macromolecular endoplasmic reticulum
11/03/1992	US5160737 Acrylic copolymer; sustained release; dentistry, dermatology
11/03/1992	US5160734 Complex with polyoxyethylene-polyoxypropylene copolymer
11/03/1992	US5160728 Sodium carbonate, neutralization, potassium carbonate
11/03/1992	US5160725 Magnetic liquid compositions
11/03/1992	US5160680 Heating, extrusion
11/03/1992	US5160669 Low temperature
11/03/1992	US5160469 Manufacture of pellets of xanthine derivatives
11/03/1992	CA2102211A1 Modified pollen grains for delivering biologically active substances to plants and animals
11/03/1992	CA1309661C Transdermal delivery system
11/03/1992	CA1309659C Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
11/03/1992	CA1309657C Biodegradable microspheres as a carrier for macromolecules
11/03/1992	CA1309656C Sustained-release drug preparation
10/1992
10/30/1992	CA2067307A1 Optimized tablet formulation
10/29/1992	WO1992018519A1 Novel cytarabine derivatives, their production and use
10/29/1992	WO1992018227A2 Stable multiple emulsions
10/29/1992	WO1992018169A1 An organ specific emulsion
10/29/1992	WO1992018165A2 Improved fluorocarbon contrast media for use with mri and radiographic imaging
10/29/1992	WO1992018164A1 Preparation of diagnostic agents
10/29/1992	WO1992018147A1 Convertible microemulsion formulations
10/29/1992	WO1992018136A1 Blood substitutes and organ preservative solutions
10/29/1992	WO1992018128A1 Methods and compositions for treatment of infection by intracellular parasites
10/29/1992	WO1992018124A1 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST
10/29/1992	WO1992018121A1 Thiocarbamate sulfoxide composition for deterring ethanol ingestion
10/29/1992	WO1992018112A1 Method of preventing nmda receptor complex-mediated neuronal damage
10/29/1992	WO1992018111A2 Pharmaceutical composition for the treatment of gastritis
10/29/1992	WO1992018110A1 Process for conditioning of water-soluble substances
10/29/1992	WO1992018106A1 Method of manufacturing solid dispersion
10/29/1992	WO1992018105A1 Improvements in pharmaceutical compositions
10/29/1992	WO1992018104A1 Pharmaceutical formulation and process
10/29/1992	WO1992018103A1 Method for the formation of liposomes and compositions for use therein
10/29/1992	WO1992018102A1 Dosage forms comprising polymers comprising different molecular weights
10/29/1992	WO1992018101A1 Vaginal drug delivery device
10/29/1992	WO1992018099A1 An agent for animal skin treatment
10/29/1992	WO1992018095A1 Antimicrobial oral compositions
10/29/1992	DE4113048A1 Controlled release pharmaceuticals - have PVA partially acetalised with butyraldehyde as matrix former
10/29/1992	CA2109094A1 An organ specific emulsion
10/29/1992	CA2083260A1 Preparation of diagnostic agents
10/28/1992	EP0511118A1 Use of lysine and or arginine pyrrolidone carboxylate as anti-oxydant agent in a cosmetic or pharmaceutical composition
10/28/1992	EP0510748A1 Use of a methoxy alkanoic acid of indazole for the manufacture of a medicament for the treatment of autoimmune diseases
10/28/1992	EP0510731A1 LHRH Analog formulations
10/28/1992	EP0510687A2 Infusion preparation
10/28/1992	EP0510561A1 Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam
10/28/1992	EP0510404A1 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
10/28/1992	EP0510210A1 Procaterol-containing plaster
10/28/1992	EP0510197A1 Fat emulsion
10/28/1992	EP0510186A1 Therapeutic uses of melanin
10/28/1992	EP0510165A1 Amphiphilic non-ionic, glycerol-derived compounds, a method for preparing same, corresponding intermediate compounds and compositions containing said compounds.
10/28/1992	EP0510119A1 Aqueous core microcapsules and method for their preparation
10/28/1992	EP0321499B1 Covalently bonded active agents with carbonium ion base groups
10/27/1992	US5158944 Dispersed in excipient readily soluble in organic solvent, and basic substance
10/27/1992	US5158881 Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
10/27/1992	US5158804 Controlled vibration, intermittent spraying
10/27/1992	US5158789 Melt cocrystallized sorbitol/xylitol compositions
10/27/1992	US5158779 Particles of hydrophobic or sparingly soluble substance
10/27/1992	US5158778 Stable antimicrobial dialdehyde composition and methods of use
10/27/1992	US5158777 Captopril formulation providing increased duration of activity
10/27/1992	US5158776 Includes microcrystalline cellulose
10/27/1992	US5158775 Aerosols of pyrido [1,2-a]pyrimidine compounds
10/27/1992	US5158774 Method of treating yeast infection
10/27/1992	US5158772 Beta-1,3-glucan-type polysaccharide
10/27/1992	US5158769 Genetic engineering; polypeptide protective coating for vaccine
10/27/1992	US5158766 Storage stable aqueous soluble germicidal film forming composition
10/27/1992	US5158761 Spray gel base and spray gel preparation using thereof
10/27/1992	US5158704 Supercritical fluid reverse micelle systems
10/27/1992	US5158536 Temporarily filling air passages
10/27/1992	CA1309355C Hydrogen peroxide-releasing tooth powder
10/27/1992	CA1309352C Method and composition for reducing serum cholesterol
10/27/1992	CA1309351C Compositions containing ibuprofen
10/27/1992	CA1309348C Ophthalmic composition containing polysiloxane
10/27/1992	CA1309347C Delayed/sustained release of macromolecules
10/27/1992	CA1309346C Pharmaceutical administration systems containing chemotactic peptides
10/27/1992	CA1309345C Controlled release drug delivery system for the periodontal pocket
10/24/1992	WO1992018239A1 Process for making whey-derived fat substitute product and products thereof
10/24/1992	CA2066917A1 Polymer composition for tooth bleaching and other dental uses thereof

1 ... 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 ... 2991